BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 19964736)

  • 1. Studies in drug transport vs. current in iontophoretic onychomycosis treatment.
    Barsness M; Davis SP; Etheredge R; Chang K; Kim H
    Annu Int Conf IEEE Eng Med Biol Soc; 2009; 2009():289-94. PubMed ID: 19964736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transungual delivery of terbinafine by iontophoresis in onychomycotic nails.
    Nair AB; Vaka SR; Murthy SN
    Drug Dev Ind Pharm; 2011 Oct; 37(10):1253-8. PubMed ID: 21457120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An ex vivo toe model used to assess applicators for the iontophoretic ungual delivery of terbinafine.
    Nair AB; Kim HD; Davis SP; Etheredge R; Barsness M; Friden PM; Murthy SN
    Pharm Res; 2009 Sep; 26(9):2194-201. PubMed ID: 19582550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iontophoretic delivery of terbinafine in onychomycosis: a preliminary study.
    Amichai B; Nitzan B; Mosckovitz R; Shemer A
    Br J Dermatol; 2010 Jan; 162(1):46-50. PubMed ID: 19785609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nail incorporation kinetics of terbinafine in onychomycosis patients.
    Schatz F; Bräutigam M; Dobrowolski E; Effendy I; Haberl H; Mensing H; Weidinger G; Stütz A
    Clin Exp Dermatol; 1995 Sep; 20(5):377-83. PubMed ID: 8593713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iontophoresis for drug delivery into the nail apparatus: exploring hyponychium as the site of delivery.
    Kushwaha A; Shivakumar HN; Murthy SN
    Drug Dev Ind Pharm; 2016 Oct; 42(10):1678-82. PubMed ID: 26981643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iontophoretic terbinafine delivery in onychomycosis: questionable nail growth.
    Oon HH; Tan HH
    Br J Dermatol; 2010 Mar; 162(3):699-700. PubMed ID: 20030642
    [No Abstract]   [Full Text] [Related]  

  • 8. Trans-ungual iontophoretic delivery of terbinafine.
    Nair AB; Vaka SR; Sammeta SM; Kim HD; Friden PM; Chakraborty B; Murthy SN
    J Pharm Sci; 2009 May; 98(5):1788-96. PubMed ID: 18781625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iontophoretic terbinafine HCL 1.0% delivery across porcine and human nails.
    Amichai B; Mosckovitz R; Trau H; Sholto O; Ben-Yaakov S; Royz M; Barak D; Nitzan B; Shemer A
    Mycopathologia; 2010 May; 169(5):343-9. PubMed ID: 20012894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ungual and trans-ungual iontophoretic delivery of terbinafine for the treatment of onychomycosis.
    Nair AB; Kim HD; Chakraborty B; Singh J; Zaman M; Gupta A; Friden PM; Murthy SN
    J Pharm Sci; 2009 Nov; 98(11):4130-40. PubMed ID: 19340887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.
    Gupta AK
    J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S81-95. PubMed ID: 11051137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly.
    Gupta AK; Konnikov N; Lynde CW
    J Am Acad Dermatol; 2001 Mar; 44(3):479-84. PubMed ID: 11209118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid Treatment of Subungual Onychomycosis Using Controlled Micro Nail Penetration and Terbinafine Solution.
    Bristow I; Baran R; Score M
    J Drugs Dermatol; 2016 Aug; 15(8):974-8. PubMed ID: 27537998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled-release injectable containing terbinafine/PLGA microspheres for onychomycosis treatment.
    Angamuthu M; Nanjappa SH; Raman V; Jo S; Cegu P; Murthy SN
    J Pharm Sci; 2014 Apr; 103(4):1178-83. PubMed ID: 24497012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The successful treatment of Trichophyton rubrum nail bed (distal subungual) onychomycosis with intermittent pulse-dosed terbinafine.
    Zaias N; Rebell G
    Arch Dermatol; 2004 Jun; 140(6):691-5. PubMed ID: 15210459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of toe-nail onychomycosis treated with terbinafine.
    Brandrup F; Larsen PO
    Acta Derm Venereol; 1997 May; 77(3):238. PubMed ID: 9188883
    [No Abstract]   [Full Text] [Related]  

  • 17. Recent progress on the topical therapy of onychomycosis.
    Alley MR; Baker SJ; Beutner KR; Plattner J
    Expert Opin Investig Drugs; 2007 Feb; 16(2):157-67. PubMed ID: 17243936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Terbinafine hydrochloride loaded liposome film formulation for treatment of onychomycosis: in vitro and in vivo evaluation.
    Tanrıverdi ST; Hilmioğlu Polat S; Yeşim Metin D; Kandiloğlu G; Özer Ö
    J Liposome Res; 2016; 26(2):163-73. PubMed ID: 26226352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 12-week treatment for dermatophyte toe onychomycosis: terbinafine 250 mg/day vs. itraconazole 200 mg/day--a double-blind comparative trial.
    De Backer M; De Keyser P; De Vroey C; Lesaffre E
    Br J Dermatol; 1996 Jun; 134 Suppl 46():16-7: discussion 38. PubMed ID: 8763462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Itraconazole and terbinafine treatment of some nondermatophyte molds causing onychomycosis of the toes and a review of the literature.
    Gupta AK; Gregurek-Novak T; Konnikov N; Lynde CW; Hofstader S; Summerbell RC
    J Cutan Med Surg; 2001; 5(3):206-10. PubMed ID: 11685666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.